Stock market today: Nasdaq clobbered, S&P 500 tumbles as AI fears rock Nvidia, tech stocks
The tech-heavy Nasdaq Composite ( ^IXIC) sank nearly 3.5%, while the S&P 500 ( ^GSPC) dropped nearly 2%. The blue-chip Dow Jones Industrial Average ( ^DJI ), which is less dependent tech stocks, bucked the trend, rising 0.1%.
Stock Market Today: Nasdaq, S&P 500 down sharply as DeepSeek fears spark $1.1 trillion tech rout, Nvidia drops 14%; Dow turns positive
The Dow is up roughly 0.3%, versus a fall of 3.11% for the Nasdaq. If it holds, the Dow's 3.41 percentage point outperformance would be its strongest versus the Nasdaq since Nov. 9, 2020, according to Dow Jones Market Data, when the blue-chip gauge outpaced the tech-heavy index by 4.47 percentage points.
Biggest Market Loss In History: Nvidia Stock Sheds Nearly $600 Billion As DeepSeek Shakes AI Darling
Nvidia lost more market value Monday than the total valuations of American stalwarts UnitedHealth, Costco and Bank of America.
U.S. stock markets tumble as investors worry about DeepSeek
U.S. tech stocks plunged on Monday, amid a wider market sell-off. The culprit: DeepSeek, a Chinese artificial intelligence company that last week introduced a new — and low-cost — model into the red-hot AI tech market.
Stock Market Today: Nvidia Stock Sinks in AI Rout Sparked by China's DeepSeek
After China's DeepSeek prompts AI rethink, Nvidia stock slides. Follow along for live updates on stocks and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.
Nvidia Stock Slashes Nearly $600 Billion in Market Value. What’s Driving the Panic and Why It May Be Overblown.
Shares of semiconductor makers were dropping early Monday as a Chinese AI model triggered questions over their lofty valuations.
China's DeepSeek AI model shocks the world: Should you sell your Nvidia stock?
DeepSeek stunned the tech world with the release of its R1 "reasoning" model, matching or exceeding OpenAI's reasoning model for a fraction of the cost.
US Stock Futures Sink as Investors Weigh China Challenge to US Dominance in AI. Nvidia Drops 12%
Investors dumped technology stocks in premarket trading Monday, sending U.S. indexes sharply lower after Chinese artificial intelligence startup DeepSeek demonstrated a chatbot that it says rivals the
DeepSeek sparks AI stock selloff; Nvidia posts record market-cap loss
By Sinéad Carew, Amanda Cooper, Ankur Banerjee NEW YORK/LONDON/SINGAPORE (Reuters) -Global investors dumped tech stocks on Monday as they worried that the emergence of a low-cost Chinese artificial intelligence model would threaten the dominance of AI leaders like Nvidia,
Nvidia and the market's favorite tech darlings are getting crushed by DeepSeek's AI push
A major tech stock sell-off ensued Monday as the debut of DeepSeek rattled investors. Nvidia, Alphabet, and Microsoft were among the biggest losers.
Why Is DeepSeek Sinking Nvidia Stock?
According to a paper authored by the lab, the DeepSeek-R1 model outperforms cutting-edge models such as OpenAI’s o1 and ...
AI-Fueled Stock Rally Gets $1 Trillion Jolt From China Upstart
For the better part of two years, artificial intelligence technologies have been a nonstop gift for US equities investors.
What is DeepSeek, the Chinese AI company upending the stock market?
A frenzy over an artificial intelligence chatbot made by Chinese tech startup DeepSeek was upending stock markets Monday and ...
The AI-stock wipeout lays bare 2 risks investors have been happy to ignore - until now
DeepSeek has complicated the dominant narrative that's propped up the market for the last 2 years, challenging lofty ...
Super Micro Computer Stock: Where Is It Heading In 2025?
Is Super Micro Computer a good investment in 2025? Get insights into its projected growth, financial outlook, and potential ...
SoundHound AI: Overvaluation And Mixed Technicals Make Stock A Sell
SoundHound's fundamentals are strong, with significant revenue growth and narrowed net losses, but the valuation is ...
Why AbbVie Stock Popped While the Market Flopped on Monday
AbbVie is one of the better pharmaceutical stocks on the scene, buttressed by a strong product lineup and a promising ...